Dr. James Joseph Worry Ii, DHSC, MPAS, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 1220 Lincoln Way, Suite 101, White Oak, PA 15131 Phone: 412-678-8806 |
Mr. Robert Wayne Weiser, PA-C Physician Assistant - Surgical Medicare: Accepting Medicare Assignments Practice Location: 2001 Lincoln Way, White Oak, PA 15131 Phone: 412-672-7154 Fax: 412-672-7159 |
Molly Berkowitz, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 2001 Lincoln Way, White Oak, PA 15131 Phone: 724-972-2641 |
Cara L Karls, Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 1220 Lincoln Way, Suite 201, White Oak, PA 15131 Phone: 412-673-2200 Fax: 412-673-3205 |
Kayla Hess, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 1220 Lincoln Way Ste 101, White Oak, PA 15131 Phone: 126-788-8064 Fax: 126-783-7804 |
Amanda Weishar Patterson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1220 Lincoln Way, White Oak, PA 15131 Phone: 412-678-8806 |
News Archive
University of Alberta researchers have found the Ebola polymerase (enzyme), which may lead to more effective research and better treatments for the often fatal infection, and other related viral diseases.
BRCA gene mutation has been associated with cancers such as breast cancer. The BRCA gene mutation detection had resulted in a prophylactic double mastectomy for actress Angelina Jolie anticipating cancer. Now a new study has shown that having a BRCA gene mutation and being diagnosed with breast cancer does not raise the risk of death after diagnosis. The study was published in the latest issue of the journal The Lancet Oncology.
A review of nutrition and weight-loss interventions for people with impaired mobility found strategies are sorely lacking for people with neurological disabilities, according to a team of researchers from Case Western Reserve University and Cleveland Clinic.
Bionomics Limited, a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of diseases of the central nervous system (CNS) and cancer, today reported positive data from the completed Phase 1 multiple ascending dose, placebo controlled clinical trial of BNC210, an orally administered negative allosteric modulator of the alpha-7 nicotinic acetylcholine receptor (alpha-7 receptor) being developed for the treatment of anxiety and depression.
Exposure to radon gas in homes is the second leading cause of lung cancer after smoking, according to a study carried out by researchers from the University of Cantabria and the Babes-Bolyai University in Romania. The team has studied data on exposure to this element in a uranium mining area in Transylvania and in an area of granite in Torrelodones, Madrid
› Verified 5 days ago